Gout is a treatable form of arthritis that is associated with...
April 2018
Urate-lowering medicines should be considered and discussed...
April 2018
This report provides data on the use of vitamin D supplementation...
September 2016
In 2011, bpacnz produced guidance on vitamin D supplementation...
August 2016
Ankylosing spondylitis is a relatively uncommon inflammatory...
August 2016
Chronic pelvic pain can cause significant disruption to the...
September 2015
This report provides an update on the use of bisphosphonates...
November 2014
Muscle pain (myalgia) and weakness is experienced by up to 10%...
August 2014
Febuxostat was added to the New Zealand Pharmaceutical Schedule...
July 2014
Diabetic peripheral neuropathy is one of the most common long-term...
June 2014
In New Zealand, the majority of people with gout have higher...
April 2014
Gout is a common form of inflammatory arthritis that is caused...
April 2014
Bone density loss leading to osteoporosis is a risk for patients...
November 2013
Risedronate has been fully subsided in New Zealand without restriction...
November 2013
A number of clinical syndromes are associated with the precipitation...
October 2013
Managing urinary incontinence goes beyond just treating the...
October 2013
Multiple sclerosis (MS) is an inflammatory disease of the central...
August 2013
Polymyalgia rheumatica is an inflammatory condition that causes...
June 2013
The management of gout involves treatment of an acute
attack,...
March 2013
Restless legs syndrome is a common neurological disorder that...
December 2012
Gout has a significant impact on Māori in New Zealand. Management...
August 2011
Counties Manukau DHB Māori Gout Action Group have identified...
August 2011
Despite the increasing focus on vitamin D levels and claimed...
June 2011
When used and monitored correctly methotrexate can be an effective...
February 2011
A short article on gout with specific reference to Pacific...
November 2010
• Iodine supplements now funded
• Zoledronic acid now funded
• Atorvastatin...
August 2010
Nicotinic acid/laropiprant (Tredaptive) ▪ Fosamax Plus...
November 2009
Tumour necrosis factor (TNF) inhibitors are used in the treatment...
November 2009
Instructions and illustrations for performing a quick examination...
June 2009
The use of oral fluoroquinolones is associated with increased...
June 2009
Acute low back pain is common and most patients will fully recover...
June 2009
Key aspects of management include reassurance, education and...
June 2009
An introduction to FRAX, a new WHO endorsed approach for the...
November 2008
Acute monoarthritis is characterised by pain and swelling of...
November 2008
Reference tool for calculating risk of major osteoporatic ...
November 2008
Osteoporosis and subsequent fracture may be prevented by maintaining...
October 2008
The key treatment of osteoarthritis is to provide information...
October 2008
Most people with rheumatoid arthritis require early treatment...
October 2008
Gout is a significant health issue for Māori. This article...
May 2008
It is generally accepted that the use of Depo-Provera results...
April 2008
The development and marketing of anti-ageing products is a multi-million...
February 2008
Contributed by Safe and Quality Use of Medicines.
September 2007
Gout is an arthritis caused by the inflammatory response to...
September 2007
What is the significance of the warning between ACE inhibitors...
June 2007
from BNP/Haemochromatosis/Vitamin D: Testing in Primary CareThis...
January 2007
Cardiovascular risk associated with NSAIDs and coxibsNSAIDs...
October 2006
The aim of this POEM is to support the safer use of NSAIDs including...
December 2004
Nocturnal leg cramps are common, particularly in older people...
December 2012